SOURCE: Power3 Medical Products, Inc.

September 14, 2011 14:05 ET

Power3 Medical's Goldknopf to Deliver Keynote in Beijing

HOUSTON, TX--(Marketwire - Sep 14, 2011) - Power3 Medical Products, Inc. (OTCBB: PWRM), a biotechnology company, announced today that President and Chief Scientific Officer Dr. Ira L. Goldknopf will deliver a keynote address to the International Congress and Exposition of Molecular Diagnostics in Beijing, China, September 22, 2011.

"A panel of diagnostic leaders selected Dr. Goldknopf for the Keynote Forum opening the meeting. His talk, 'Navigating the Waters of Omic Medicine for Alzheimer's Disease,'" said Helen R. Park, MS, CEO of Power3, "addresses key obstacles." Also, Dr. Goldknopf will chair a session: Diagnostic Biomarkers for CNS Diseases and Genetic Disorders.

Power3 has patents pending, an exclusive license from Baylor College of Medicine, has delivered 9 presentations at international scientific meetings, and published 6 articles in scientific journals on NuroPro®.

Power3 Medical Products

Power3 Medical Products, Inc. a leading bio-technology company develops innovative diagnostic tests in neurodegenerative diseases (NuroPro®): Alzheimer's disease, Parkinson's disease and ALS (Lou Gehrig's disease) and cancer (BC-SeraPro™), discovers protein biomarkers and tests to detect disease, progression, drug response, and disease mechanisms.

For more information, please visit http://www.power3medical.com.

Safe Harbor Provision

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact, including, without limitation, statements regarding the company's future financial position, business strategy, budgets, projected revenues and costs, and plans and objectives of management for future operations, are forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from results proposed in such statements. Although the company believes that the expectations reflected in such forward-looking statements are reasonable, it can provide no assurance that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2010 and its other filings and submissions with the Securities and Exchange Commission.

Contact Information

  • Contact:
    Crown Equity Holdings, Inc.
    Ken Bosket
    877-854-6797 or 702-448-1543